🔓 Unlock the full profile of Sanjay Mahajan (Prince Pharma Sarl), including verified contact details, financial insights, and professional associations.
See Sanjay Mahajan Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: san***@**************rl.***
Mobile: ***6***38*
Estimated Net Worth 💰 : ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Key Insights You Should Know About This Individual
- Sanjay Mahajan currently serves as the Group Chief Executive Officer of Prince Pharma SARL, Davimed & Afriphar, a role he has held since April 2024, where he is responsible for steering the strategic direction and operational excellence of the organization.
- Prior to his current position, Mahajan was the Chief Executive Officer for Africa at Cadila Pharmaceuticals Limited from October 2022 to April 2023, where he played a pivotal role in expanding the company's footprint in the African market.
- During his tenure as Chief Operating Officer at Shalina Healthcare from January 2021 to August 2022, Mahajan was instrumental in optimizing operational processes, which significantly improved efficiency and productivity across the organization.
- As Chief Commercial Officer at Shalina Healthcare from August 2019 to January 2021, Mahajan led initiatives that enhanced market penetration and revenue growth, demonstrating a strong ability to drive commercial success in competitive environments.
- Mahajan's leadership as President of Business Development at Shalina Healthcare from December 2017 to August 2019 was marked by successful partnerships and collaborations that expanded the company's product offerings and market reach.
- In his role as Vice President for Africa & South East Asia at Kopran Limited from December 2013 to September 2014, Mahajan developed strategic initiatives that strengthened the company's market position in these regions.
- Mahajan's extensive experience at Glenmark Pharmaceuticals, where he held various senior roles including Vice President of International Business and Vice President for Africa, Middle East, and GCC, contributed to significant growth and expansion strategies that enhanced the company's global presence.
- Throughout his career, Mahajan has demonstrated a commitment to innovation in the pharmaceutical sector, focusing on developing and implementing strategies that address market needs and improve healthcare access.
- His early career at Cadila Pharmaceuticals and Dr. Reddy's Laboratories laid a strong foundation in regional business management, where he honed his skills in market analysis and strategic planning.
- Mahajan's leadership style emphasizes collaboration and empowerment, fostering a culture of excellence and accountability within the teams he leads, which has been crucial in achieving organizational goals and driving sustainable growth.
Disclaimer: All information is curated from public and third-party sources and provided solely for legitimate business use. Please ensure proper authorization before use. The depth of information depends on what is publicly available and may vary between individuals.